Inactief instrument

Andere talen Clinigen Group plc

Aandelen

CLIN

GB00B89J2419

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Clinigen Launches NaviGATE an Educational Programme for Rare Disease Patients and Organizations	12-09-23
CNX Therapeutics Limited acquired Cardioxane® (dexrazoxane), Savene® (dexrazoxane), Totect® (dexrazoxane) and Ethyol®, four cancer support therapies from Clinigen Limited.	10-08-23
Clinigen Limited Reports Earnings Results for the Full Year Ended June 30, 2022	09-05-23
Adragos Pharma GmbH completed the acquisition of Lamda Laboratories S.A. from Clinigen Limited.	03-04-23
JCR Pharmaceuticals implements IZCARGO Named Patient Supply Program	28-03-23
Clinigen : Supplier Code of Conduct 2023	28-03-23
Adragos Pharma acquires Clinigen's development unit, Lamda Laboratories	20-03-23
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories	20-03-23
Adragos Pharma GmbH signed a definitive agreement to acquire Lamda Laboratories S.A. from Clinigen Limited.	20-03-23
Clinigen : Global Human Rights & Anti Slavery Policy	10-03-23
Clinigen : Global Anti-Bribery & Corruption Policy	10-03-23
Clinigen : Global Anti-Money Laundering Policy	10-03-23
Clinigen : Global Anti-Trust Policy	10-03-23
Clinigen : Global Health & Safety Policy	10-03-23
Clinigen : Global Freedom to Speak Up Policy	10-03-23
Clinigen : Global Data Protection Policy	10-03-23
Clinigen : Global Diversity, Equity & Inclusion Policy	10-03-23
Clinigen : Global Environmental Policy	10-03-23
Clinigen : Global Human Rights & Anti Slavery Policy	03-02-23
Iovance Biotherapeutics, Inc. entered into a definitive agreement to acquire Worldwide rights of Proleukin of Clinigen Limited for approximately £210 million.	23-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Clinigen Group plc

Aandelen

CLIN

GB00B89J2419

Andere talen

Filters